Skip to main content

Table 3 Analysis of COX-2 8473T>C genotype frequencies, ORs and 95% CIs for adenocarcinoma by selected variables

From: Relationship between cyclooxygenase 8473T>Cpolymorphism and the risk of lung cancer: a case-control study

Variable

Genotype, no (%)

  
 

Cases

Controls

OR (95% CI) for TC + CC vs TT

 

TT

TC

CC

TT

TC

CC

Crude

Adjusted

Gender

   Male

86 (68.2)

35 (27.8)

5 (4.0)

265 (56.8)

175 (37.5)

27 (5.8)

0.61 (0.40–0.93)a

0.59 (0.39–0.91)a,b

   Female

51 (64.6)

25 (31.7)

3 (3.8)

65 (56.5)

45 (39.1)

5 (4.4)

0.71 (0.40–1.29)

0.72 (0.40–1.30)b

Age (years)

   ≤60

69 (62.7)

39 (35.5)

2 (1.8)

158 (55.1)

115 (40.1)

14 (4.9)

0.73 (0.46–1.14)

0.74 (0.47–1.16)c

   >60

68 (71.6)

21 (22.1)

6 (6.3)

172 (58.3)

105 (35.6)

18 (6.1)

0.56 (0.34–0.92)a

0.55 (0.33–0.93)c,d

Smoking status

   Never

49 (61.2)

28 (35.0)

3 (3.8)

77 (55.8)

53 (38.4)

8 (5.8)

0.80 (0.46–1.40)

0.77 (0.43–1.36)c

   Everf

88 (70.4)

32 (25.6)

5 (4.0)

253 (57.0)

167 (37.6)

24 (5.4)

0.56 (0.36–0.85)g

0.57 (0.37–0.87)e,g

Pack-years in ever-smokersf

   ≤35 pys

46 (74.2)

14 (22.6)

2 (3.2)

147 (59.0)

89 (35.7)

13 (5.2)

0.50 (0.27–0.93)d

0.51 (0.27–0.96)e,h

   >35 pys

42 (66.7)

18 (28.6)

3 (4.8)

106 (54.4)

78 (40.0)

11 (5.6)

0.60 (0.33–1.08)

0.60 (0.33–1.10)e

  1. a P = 0.02.
  2. bAdjusted for age and pack-years of smoking.
  3. cAdjusted for gender and pack-years of smoking.
  4. d P = 0.03.
  5. eAdjusted for gender and age.
  6. fFormer- and current-smokers.
  7. g P = 0.01.
  8. h P = 0.04.